LXRX FY 2014 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$729M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23M+928.5% YoY

Gross Profit

-$66M-290.6% margin

Operating Income

-$100M-439.2% margin

Net Income

-$100M-438.8% margin

EPS (Diluted)

$-1.31

Cash Flow

Operating Cash Flow

-$76M

Free Cash Flow

-$76M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$471M

Total Liabilities

$187M

Stockholders' Equity

$284M

Cash & Equivalents

$339M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$2M	+928.5%
Gross Profit	-$66M	-$87M	+24.1%
Operating Income	-$100M	-$102M	+2.0%
Net Income	-$100M	-$104M	+3.7%